FAS and cancer: Screening phytoconstituents in mistletoes, especially in the underexplored Scurrula ferruginea for bioactive FAS inhibitors with minimal toxicity/side effects and understanding their mode of action and associated target signaling pathways would pave the way for the identification of novel, anti-cancer biomolecules.